3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
20
Lung Neoplasms
9
NSCLC
3
Brain Neoplasms
3
Neoplasms
2
Squamous Cell Carcinoma of Lung
1
Non-squamous Non-small Cell Lung Cancer
1
Non-small Cell Lung Cancer Metastatic
1
Non-Small-Cell Lung
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms, Second Primary
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Esophageal Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Bronchial Neoplasms
1
Breast Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Carboplatin
31
Pemetrexed
28
Radiotherapy
22
Bevacizumab
21
Cisplatin
20
Gemcitabine
18
Paclitaxel
17
Erlotinib Hydrochloride
15
Docetaxel
12
Gefitinib
8
Nivolumab
6
Mastectomy, Segmental
6
Magnetic Resonance Spectroscopy
6
pembrolizumab
5
aflutinib
5
Radiosurgery
5
tislelizumab
4
Vinorelbine
4
Surgical Procedures, Operative
4
Specimen Handling
4
Sorafenib
4
Platinum
4
Metformin
4
Biopsy
4
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
4
sargramostim
3
apatinib
3
Taxes
3
Cetuximab
3
Anterior Temporal Lobectomy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenocarcinoma of Lung
×
icotinib
×
Clear all
NCT02264210
2024-09-25
CORIN
Sun Yat-sen University
Phase 2
Completed
128 enrolled
9 charts